Close Menu

NEW YORK  – PerkinElmer said on Thursday that its SARS-CoV-2 Real-time RT-PCR assay has received the CE-IVD mark for the use of saliva as a specimen type and for sample pooling.

The assay can now be used to pool up to five specimens collected from individuals suspected of having COVID-19 or from asymptomatic patients. The test initially received CE marking in the spring.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.